Cargando…
Salivary Estrogens Androgens and Aromatase Inhibitors by LC-MS/MS in Breast Cancer Patients Treated With Testosterone Pellets Combined With Aromatase Inhibitors
Introduction: High dose testosterone (T) has been used for treating hormone-sensitive breast cancers for many years. However, a drawback to T therapy is its propensity to convert to estradiol (E2) via aromatase, which can override the growth inhibitory effects of T and stimulate estrogen sensitive t...
Autores principales: | Zava, David T, Kimball, David W, Glaser, Rebecca L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089329/ http://dx.doi.org/10.1210/jendso/bvab048.2130 |
Ejemplares similares
-
SUN-125 Phase Ib Study of Dual Therapy with an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women with Advanced Non-Small Cell Lung Cancer
por: Young, Patricia A, et al.
Publicado: (2020) -
Differentiating Between CAH and PCOS Using Hormone Levels and LC-MS/MS
por: Hauck, Zane Z, et al.
Publicado: (2021) -
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
por: Jayaraman, Swaathi, et al.
Publicado: (2020) -
A yeast screen system for aromatase inhibitors and ligands for androgen receptor: yeast cells transformed with aromatase and androgen receptor.
por: Mak, P, et al.
Publicado: (1999) -
ODP540 Aromatase interacting partner in Breast (AIPB) regulates estradiol in human breast
por: Moffitt, Alyssa M, et al.
Publicado: (2022)